Guardant Health Email Format

Biotechnology Research
1,001-2,500 employees
Palo Alto, CA, USA

Guardant Health is a precision medicine company that develops advanced blood and tissue tests, real-world data analytics, and AI solutions to detect, monitor, and guide treatment of cancer.

Find contacts at Guardant Health

Search our verified sources for decision-makers, emails, and titles.

Start searching
VERIFIED BY CLAY

firstlast@guardanthealth.com

Company Overview

Industry
Biotechnology Research
Founded
2012
Headquarters
Palo Alto, CA, USA
Revenue
$500M-$1B
FUNDING Stage
Public
Key Executives
Helmy Eltoukhy and AmirAli Talasaz (Co-founder, Chairman and co-CEO), Michael Bell (Chief Financial Officer), Darya Chudova (Chief Technology Officer)

Tech Stack

Amazon Web Services

Cloud

Signup

to know

Signup

to know

Signup

to know

Key Executives

Chief Executive Officer

Find the current person →

Chief Finance Officer

Find the current person →

Chief Operating Officer

Find the current person →

Chief Technology Officer

Find the current person →

Chief Marketing Officer

Find the current person →

Chairman

Find the current person →

4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified

Frequently Asked Questions

What is the email format of Guardant Health?

Guardant Health uses the firstlast format, so Jane Smith would be janesmith@guardanthealth.com.

What is Guardant Health's Shield blood test used for?

Guardant Health's Shield is an FDA-approved blood-based test for colorectal cancer screening in average-risk adults aged 45 and older. In 2026, the American Cancer Society added Shield to its updated colorectal cancer screening guidelines.

How does Guardant Health's Guardant360 Liquid CDx differ from traditional cancer diagnostic tests?

Guardant360 Liquid CDx is the largest FDA-approved liquid biopsy panel, delivering both genomic and epigenomic insights from a blood draw rather than a tissue biopsy. In 2026, the FDA approved an expanded version with a 100x wider genomic footprint than the previously approved panel.

Which business segments drive Guardant Health's revenue in 2026?

Guardant Health generates revenue across three segments: Oncology, Screening, and Biopharma and Data. In Q1 2026, Oncology grew 36% to $205 million and Biopharma and Data rose 17% to $53 million, with Screening also contributing to overall 48% year-over-year revenue growth.

Who leads Guardant Health as co-CEOs in 2026?

Guardant Health is co-led by Helmy Eltoukhy and AmirAli Talasaz, both co-founders who serve as co-CEOs and share the Chairman role. If you need to reach their team directly, tools like Clay can help you find and verify the right contact at Guardant Health.

Share Article

Get access to more people and company data using Clay

Leverage the power of 100+ data providers for industry-leading data coverage & quality.

4.9 rating

More Articles